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Calls for a European Health Union apparently challenge long-standing beliefs that national 
healthcare system organisation is a Member State competence. Interaction between Member 
State and European Union (EU) levels therefore fundamentally requires reflection in the 
design, overall structure and legal basis of any European Health Union. Article 168(7) Treaty 
on the Functioning of the European Union (TFEU) provides the current version of the 
seemingly limited EU competence with regards to national healthcare system organisation and 
has received surprisingly little attention thus far. On the one hand, within the wider EU health 
competence ‘web’, Article 168(7) TFEU constrains EU adoption of measures incentivising 
Member States to use particular treatments or to increase intensive care units in response to 
COVID-19. On the other hand, Article 168(7) TFEU is challenged by the perceived influence 
of Country-Specific Recommendations issued in the context of the European Semester on 
national health policies. This opinion piece provides an original assessment of Article 168(7) 
TFEU to argue that Treaty change to redress the balance between EU and Member State 
competence regarding national healthcare systems may be uncalled for given both the 





The COVID-19 pandemic is demonstrating clear benefits to coordination and cooperation at 
European Union (Union) level in tackling a global health crisis. The Socialists and Democrats 
(S&D)’s call for a European Health Union emphasises the relative powerlessness of Member 
States to act individually in the face of the COVID-19 pandemic, and the damaging effects of 
having underfunded healthcare systems and differing healthcare capacities across the Union.1 
The S&D’s call is wide-ranging, encompassing aspects as diverse as access to pharmaceuticals, 
health research, and health and safety in the workplace,2 but appears premised on a 
fundamental need for more (or more explicit) Union-level cooperation because healthcare 
systems remain the responsibility of Member States. 
Article 168(7) Treaty on the Functioning of the European Union (TFEU) provides that 
Member States have responsibilities for national health policy and healthcare system 
organisation and management, and that the Union must respect this.3 However, this provision 
                                                          
1 Group of the Progressive Alliance of Socialists & Democrats in the European Parliament, Letter from I. 
García Pérez, H. Fritzon and J. Gutteland to President von der Leyen, President Michel and Prime Minister 
Plenković. 7 May 2020. https://www.socialistsanddemocrats.eu/sites/default/files/2020-05/european-health-
union-letter-200507.pdf. 
2 S&D, “A European Health Union – Increasing EU Competence in Health – Coping with COVID19 and 
Looking to the Future”, S&D Position Paper, 12 May 2020. 
https://www.socialistsanddemocrats.eu/sites/default/files/2020-
05/european_health_union_sd_position_30512.pdf. 
3 Connections with national healthcare laws and practices of Article 35 Charter of Fundamental Rights of the 
European Union are not considered here.  
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is considered to add little to the formal division of powers elsewhere in the Treaties,4 such 
that its constraining power on Union action may be considered primarily political, rather than 
legal.5 Narratives explaining national reluctance to cede power over healthcare systems to the 
Union level generally emphasise the latter’s economic significance and socio-political 
consequence, as well as the prominence accorded to health, as distinct from other aspects of 
social policy.6 A seemingly logical consequence of this is that the Union’s response appeared 
initially constrained by the present framework, which developed “because the Member States 
wanted it so”.7 
Current framing of Article 168(7) TFEU suggests it represents exclusively an impediment to 
Union action in combatting the COVID-19 pandemic, inhibiting the Union’s ability to provide 
either comprehensive solutions to a complex and evolving situation,8 or a corrective to 
national policies governing COVID-19 responses.9 This contrasts sharply with a previous 
“counter-narrative” of Member State competence regarding national health policy and 
healthcare system organisation being challenged by wider Union action, notably in connection 
with Union-level fiscal policy and assessment of national economic policies. A specific example 
of this is the Country-Specific Recommendations (CSRs)10 issued by the Commission to 
Member States in the context of the annual European Semester cycle, intended to coordinate 
economic policies across the Union. This aspect of Union policy is examined here primarily 
for offering an additional perspective on Union-Member State interaction beyond 
considerations of the limited scope for harmonisation, which are examined elsewhere.11 
This paper seeks to clarify the role for Member States within a European Health Union by 
reference to the parameters of Article 168(7) TFEU and the “counter-narrative” associated 
with CSRs (Section II). It emerges that Article 168(7) TFEU may provide at best a porous 
barrier to Union-level intervention in national healthcare,12 and that it can be more correct 
                                                          
4 S.L. Greer, N. Fahy, S. Rozenblum, H. Jarman, W. Palm, H.A. Elliott, M. Wismar, Everything You Always Wanted 
to Know about European Union Health Policies But Were Afraid To Ask, Second Edition, WHO/European 
Observatory on Health Systems and Policies, 2019, page 63. 
5 Consistent with wider considerations of Union ability to take action in health-related matters. See further 
K.P. Purnhagen, A. de Ruijter, M.L. Flear, T.K. Hervey, A. Herwig, “More Competences than You Knew? The 
Web of Health Competence for European Union Action in Response to the COVID-19 Outbreak”, (2020) 
European Journal of Risk Regulation, 11, 297-306. 
6 See further, E. Brooks and A. de Ruijter, “Toward more comprehensive law and policy research”, in EU 
Health Law and Policy – Shaping a Future Research Agenda, Health Economics, Policy and Law Special Issue, guest 
edited by E. Brooks and M. Guy (forthcoming).  
7 A. de Ruijter and S.L. Greer, “EU health law and policy in and after the COVID-19 crisis”, (2020) European 
Journal of Public Health, 1-2.  
8 S.L. Greer, “How did the EU get the Coronavirus so wrong? And what can it do right next time?”, The New 
York Times, April 6, 2020. 
9 Disappointment having been expressed that the Union level could be a place to challenge national policies 
regarding COVID-19 intensive care guidelines potentially violating the rights of older and disabled patients. 
D.M.R. Townend, B. Wouters, R. van de Pas, E. Pilot, “What is the Role of the European Union in the COVID-
19 Pandemic?”, Medicine and Law, June 2020. 
10 N. Azzopardi-Muscat et al., “EU Country-Specific Recommendations for health systems in the European 
Semester process: Trends, discourse and predictors”, (2015) Health Policy 119, 375-383. S. Garben, 
“Supporting Policies”, chapter 38 in (eds) Pieter Jan Kuiper, Fabian Ambtenbrink, Deidre Curtin, Bruno De 
Witte, Alison McDonnell, Stefaan Van den Bogaert, The Law of the European Union, Fifth Edition, Wolters 
Kluwer, 2018. 
11 For example, Purnhagen et al., supra, note 5.  
12 Art. 168 TFEU has been depicted as a gate in a field around which sheep representing EU policies as diverse 
as the internal market, agriculture and trade are free to roam. Greer et al., supra, note 4, page 176. 
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to speak of an interconnected, even symbiotic, relationship between the Member State and 
Union levels.  
These insights provide a basis for considering current national responses to the COVID-19 
pandemic (Section III). This prompts further questions of what national “health policy” means 
at present, including whether continuation of non-COVID-19 health services amounts to a 
sequential third response phase, or runs concurrently with the systematisation of phase 1 (the 
emergency) and phase 2 (relaxation of national risk responses).13 A further question is how 
the interconnected relationship between Member State and Union levels operates in each of 
these phases. 
The analysis in this paper concludes that the role for Member States in a European Health 
Union by reference to Article 168(7) TFEU is significant. It is notable that the S&D’s call 
operates around Article 168(7) TFEU, as do other proposals14 for Union-level activity in 
tackling the pandemic henceforth. While this may be logical in view of the current framework, 
it nevertheless implies that Article 168(7) TFEU provides an important basis for building a 
European Health Union, or at least that this should offer a focal point to indicate the 
importance of addressing national health policy and healthcare system organisation and its 
interaction with Union-level activity. Making use of other aspects of Union policy such as the 
European Semester, as the S&D’s call suggests, could provide an important supplement to 
action taken in connection with the wider public health elements of Article 168 TFEU. 
II. NATIONAL HEALTH POLICY AND NATIONAL HEALTHCARE SYSTEM 
ORGANISATION: AN INTERCONNECTED RELATIONSHIP BETWEEN MEMBER STATES 
AND THE UNION 
 
1. The parameters of Article 168(7) TFEU 
A “subsidiarity clause for healthcare”15 was introduced with the Maastricht Treaty,16 and 
underwent four subtle, but ultimately significant, amendments in its evolution to Article 168(7) 
TFEU:17 a decoupling of the subsidiarity focus on healthcare from “public health”; a change in 
Union focus from “fully respecting” to merely “respecting” Member State responsibilities; 
explicit stipulation of “health policy” alongside these; and elaboration, in a new second 
sentence, of what the responsibilities include.  
                                                          
13 A. Alemanno, “The European Response to COVID-19: From Regulatory Emulation to Regulatory 
Coordination?”, (2020) European Journal of Risk Regulation, 11, 307-316. 
14 See, for example, Purnhagen et al. supra, note 5, and de Ruijter and Greer (2020), supra, note 7. 
15 L. Hancher and W. Sauter, EU Competition and Internal Market Law in the Health Care Sector, Oxford 
University Press, Oxford 2012., Paragraph 1.27, page 10. 
16 Art. 152(5) Treaty on the European Union (TEU), which read “Community action in the field of public 
health shall fully respect the responsibilities of the Member States for the organisation and delivery of health 
services and medical care.[…]”. It is noted that the original iteration of the Union public health Treaty 
competence – Art. 129 EC – did not include a subsidiarity element. For background to this provision, see T.K. 
Hervey and J.V. McHale, Health Law and the European Union, CUP 2004, pages 72-84, and Hervey and de 
Ruijter in this issue.  
17 All four changes appear to have taken place in the period between October 2003 and October 2004, 
according to drafts issued as part of CIG 4/03 (page 335-337 (article III-179); 06.10.2003 and CIG 87 REV2/04 
(page 217) (article III-279), 29.10.2004. The wording was retained in drafts from other discussions, notably 
CIG 2007 Lisbon. 
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Article 168(7) TFEU thus reads: 
“Union action shall respect the responsibilities of the Member States for the definition of their 
health policy and for the organisation and delivery of health services and medical care. The 
responsibilities of the Member States shall include the management of health services and 
medical care and the allocation of the resources assigned to them.[…]”  
The framing of Article 168(7) TFEU has been considered to read as a mere elaboration of the 
extent of Member State competence, and indeed a clarification of the exclusive competence 
of Member States.18 However, the “downgrade” of Union action – to merely “respecting” 
Member State responsibilities – was considered already in 2011 both “to leave open more 
room for [Union] involvement…”, and to introduce “a delicate and sophisticated balance 
between the [Union] and national competences in health care.”19  
Such “a delicate and sophisticated balance” and juxtaposition of the “statements of national 
autonomy”20 of the second sentence of Article 168(7) TFEU can be illustrated – with the 
benefit of hindsight – by reference to Union fiscal policy reforms. It appears logical to suggest 
that Member States would have responsibility for resource allocation within national 
healthcare systems. However, “the allocation of resources assigned to them” may also be 
interpreted as Union activity influencing the (financial) resources assigned to the Member 
States,21 according to the level of fiscal oversight a Member State has been subject to following 
the 2008 economic crisis. This appears to support a long-standing consideration that “explicit 
stipulations…and implicit understanding of the subsidiarity principle…proved not to be the 
“guarantees” of no [Union] interference in national health care services that they were often 
held to be.”22  
This porousness of the apparent barrier of Article 168(7) TFEU enables a further conception 
of the interrelation between Union and national competence to emerge as an interconnected 
relationship, now illustrated by reference to Union fiscal policy. 
2. Article 168(7) TFEU and the CSRs of the European Semester 
The European Semester and its CSRs have been deemed “a particularly coercive form of soft 
law”,23 with considerable impact on the policy space of national executive governments and 
parliaments.24 The CSRs have developed to cover health matters, both in terms of the actors 
                                                          
18J-C Piris, The Lisbon Treaty – A Legal and Political Analysis. CUP 2010. Page 321. 
19 J.W. van de Gronden and E. Szyszczak, “Conclusions: Constructing a “Solid” Multi-Layered Health Care 
Edifice”, in eds. J.W. van de Gronden, E. Szyszczak, U. Neergaard, M. Krajewski, Health Care and EU Law, TMC 
Asser Press, 2011. Page 486. 
20 Garben, supra, note 10. 
21 Whereby “them” equates to “Member States”, not “the management of health services and medical care”. 
Such ambiguity is arguably more evident in some language versions of Art. 168(7) TFEU (English and French) 
than others (German and Dutch).  
22 E. Mossialos, G. Permanand, R. Baeten and T. Hervey, “Health systems governance in Europe: the role of 
European Union law and policy”, Chapter 1 in (eds) E. Mossialos, G. Permanand, R. Baeten and T.K. Hervey, 
Health Systems Governance in Europe – The Role of European Union Law and Policy, CUP 2010. Page 1.  
23 S. Garben, “The Constitutional (Im)balance between “the Market” and “the Social” in the European Union”, 
(2016) 13 European Constitutional Law Review 23. 
24 F. Amtenbrink, “The Metamorphosis of European Economic and Monetary Union”, Chapter 28 in (eds) A. 
Armull and D. Chalmers, The Oxford Handbook of European Union Law, Oxford University Press 2015. Page 744.  
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involved, 25 and, since 2018, in the Semester’s role in delivering the European Pillar of Social 
Rights. The CSRs have been considered influential regarding national health policies,26 and the 
European Semester to mark a turning-point in Union approaches towards Member State 
competence regarding healthcare system organisation.27 This appears borne out by concerns 
about negative consequences for the accessibility of public healthcare in connection with the 
fiscal policies extending to Greece, Portugal and Ireland,28 and the intuition that Member State 
to determine national health policy (and indeed healthcare system organisation) becomes 
contingent (indirectly or directly) upon the fiscal policies they are obliged to engage with.29  
However, it is possible to argue that the reality of healthcare-related CSRs may be more 
nuanced than a simple narrative of the Union telling Member States what to do regarding 
national health policy.  
The idea that the interaction between Union and Member State levels may be more 
interconnected emerges when it is understood that the CSRs form an end stage of an 
assessment cycle involving both levels.30 Although some Member State involvement depends 
upon membership of the Eurozone, Country Reports provided by the Member States “feed 
into” the cycle and find reflection in the CSRs. For example, a 2015 CSR issued to France 
exhorted the removal of restrictions on access to, and exercise of, regulated professions, in 
particular as regards the health professions.31 This appears controversial32 insofar as it may 
indicate Union-level endorsement of competition reforms in national healthcare,33 but 
arguably becomes less so when viewed against wider assessment cycles, and wider policy shifts 
in French healthcare: concerns about the numerus clausus principle restricting access to 
healthcare professions was referenced in the 2011 Country Report,34 and removal of the 
numerus clausus principle has been seen as a way to increase access to healthcare in line with 
the wider Ma Santé 2022 healthcare system reform package. A further example is proposals 
for competition reforms within the Irish healthcare system. These have also received varying 
amounts of attention at Union level – from explicit inclusion of removing restrictions to 
competition in medical services within structural reforms linked with the Economic 
                                                          
25 Including commitment from DGSANTE, “European Semester: Health reforms need to continue”. Health EU 
– Newsletter 236, June 2019. https://ec.europa.eu/health/eunewsletter/236/newsletter_en Further on the 
actors involved, see Greer et al., supra, note 4, pages 155-6. 
26 Azzopardi-Muscat et al., supra, note 10. 
27 S. Greer, H. Jarman and R. Baeten, “The New Political Economy of Health Care in the European Union: The 
Impact of Fiscal Governance”, (2016) 46(2) International Journal of Health Services, 262-282. 
28 Garben, supra, note 10. 
29 For an overview of the different mechanisms, see Greer et al., supra, note 4, pages 162-164. 
30 For a visual representation of the European Semester timeline, see 
https://ec.europa.eu/info/sites/info/files/2018-european-semester-timeline_en.pdf 
31 https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32015H0818(15)&from=EN CSR 4. 
Although not formulated as a CSR, these concerns had been articulated in 2012 as well. https://eur-
lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52012DC0313&from=EN, paragraph 15.  
32 As a measure for reducing health expenditure, this CSR has also been considered to defy what is known 
about the importance about supply-induced demand in healthcare. See Greer et al., supra, note 4, page 165.  
33 For an indication of the issues involved in developing competition reforms in national healthcare by 
reference to the Union competition law framework, see M. Guy, Competition Policy in Healthcare – Frontiers in 
Insurance-Based and Taxation-Funded Systems, Intersentia 2019, Chapter 2. 




Adjustment Programme,35 to referencing Sláintecare reforms to deliver universal healthcare in 
the 2019 CSRs,36 seemingly reflecting national shifts in emphasis. 
Overall, it might be considered that challenges to Member State competence by CSRs under 
Article 168(7) TFEU lie more in the formalisation of national health policy entailing possible 
consequences for non-compliance, rather than “top-down” directions from the Union level. 
The interconnectedness between the national and Union levels vis-à-vis CSRs (if not other 
fiscal policy instruments) may suggest a flexibility and responsiveness from both levels. How 
this evolves as CSRs include both national and Union-level aspects regarding the overarching 
aim of addressing the COVID-19 pandemic,37 as well as economic imbalances, remains to be 
seen. 
III. COVID-19 RESPONSES: ALSO AN INTERCONNECTED RELATIONSHIP BETWEEN 
MEMBER STATES AND THE UNION? 
In COVID-19 responses, questions of Union-Member State interaction appears more in 
evidence regarding health policy, as opposed to healthcare system organisation.38 Whether an 
interconnected relationship is in evidence appears governed in part by how national “health 
policy” is defined, including considerations of factors with both Union-level aspects and 
potential for divergent Member State-level responses,39 such as social determinants of health40 
and digitalisation.41  
Insofar as it may be possible to characterise COVID-19 responses as “direct” and “indirect”, 
this can offer further insights into symbiosis in the interaction between the Union and Member 
State levels, and where “more Union” may or may not be welcomed at a national level. 
“Direct” COVID-19 responses can be seen with the systematisation of phases 1 (the 
emergency) and 2 (the relaxation of national risk responses).42 Within these phases, 
convergence of national policies has been identified, but deemed attributable more to a 
spontaneous regulatory emulation process than deliberate design.43 However, it is at the level 
of “direct” responses that most recommendations for greater (and temporary) Union-level 
                                                          
35 For discussion, see DGECFIN, “The Economic Adjustment Programme for Ireland”, Occasional Papers 76, 
February 2011. Page 66. 
https://ec.europa.eu/economy_finance/publications/occasional_paper/2011/pdf/ocp76_en.pdf  
36 https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52019DC0507&from=EN 
37 Already in evidence in the 2020 CSRs. https://ec.europa.eu/info/publications/2020-european-semester-
country-specific-recommendations-commission-recommendations_en 
38 The latter apparently confined to the national level – for example, discussions among economists in the 
Netherlands of whether increased costs in responding to COVID-19 necessitate (or not) a fundamental system 
change away from the “managed competition” model formally introduced in 2006. P. Jeurissen, E. Adang, F. 
Kruse and N. Stadhouders, “Coronavirus kan de zorg structureel veranderen”, ESB 105(4784) 168-170, and in 
response, M. Varkevisser and E. Schut, “Kosten corona geven geen aanleiding om zorgstelsel fundamenteel te 
hervormen”, ESB 105(4785) 204-207.  
39 See individual responses the informative series: Health Economics, Policy and Law, HEPL blog series, Country 
Responses to the Covid19 Pandemic. https://www.cambridge.org/core/journals/health-economics-policy-and-
law/hepl-blog-series-covid19-pandemic. 
40 A. Reeves, “The EU and social determinants of health in a post-COVID world”, (2020) European Journal of 
Public Health, 8 July 2020.  
41 For consideration of the effect of digitalisation on health policy more generally, see Brooks and de Ruijter, 
supra, note 6.  




intervention are pitched,44 and where “more Union” may be welcomed by Member States. 
“Direct” responses show how Union-level action may “respect” national competence and 
play a supportive role, thus indicating an overall interconnected relationship between the 
Union and Member State levels. For example, while the Union cannot determine increases in 
intensive care units,45 underlying Union frameworks may give effect to such national policies 
by facilitating access to these units in neighbouring Member States.46  
“Indirect” COVID-19 responses, in contrast, primarily address continuity of non-COVID-19-
related healthcare at national levels alongside the pandemic response.47 As such, these may 
form a distinct phase – or perhaps a sequential phase 3 – to “direct” responses, and raise 
questions about the extent to which “more Union” may be welcome. Examples of “indirect” 
responses may include temporary government support (state aid) to implement e-health 
applications underpinning, inter alia, mental health and social support services in the 
Netherlands,48 or differing levels of cooperation with private sector providers,49 for example, 
in Portugal and Ireland,50 to ensure continuity of non-COVID-19-related health services as 
public health service provision is repurposed to focus on the pandemic.  
These examples of “indirect” responses illustrate the interconnected relationship between 
the Member State and Union levels in determining applicability of Union competition law (i.e. 
the antitrust and state aid provisions). This can be broadly dependent on the degree of 
competition in a system, and exceptions to this, notably non-economic Services of General 
Economic Interest (SGEI), which are determined at Member State, rather than Union level.51 
It is considered that a decision to engage with what might otherwise be considered 
marketisation reforms is indeed a national one in line with Article 168(7) TFEU, but entails 
the consequence of Union competition law becoming applicable.52 At present, Union 
competition law has been relaxed temporarily,53 and the aforementioned Dutch state aid case 
                                                          
44 Notably in connection with “incentive measures” and Art. 168(5) TFEU. See Alemanno, supra, note 13, and 
Purnhagen et al., supra, note 5. 
45 Purnhagen et al., supra, note 5.  
46 For example, Dutch patients having access to ICU beds in Germany.  I. Wallenburg, P. Jeurissen, J-K. 
Helderman, R. Bal, “The Netherlands’ Response to the Coronavirus Pandemic – Update (May 2020)”, 
https://www.cambridge.org/core/blog/2020/04/06/the-netherlands-response-to-the-coronavirus-pandemic/. 
47 Addressing long-term health effects of COVID-19 may also merit consideration in this connection. 
48 As was recently approved in the state aid case, Case SA.57897 Covid-19: E-Health at home 2.0. 
49 This may also play a part in “direct” responses – for example supporting COVID-19 testing efforts, as noted 
in the Czech Republic. O. Löblová, “The Czech Republic’s Response to the Coronavirus Pandemic” 22 May 
2020. https://www.cambridge.org/core/blog/2020/04/07/the-czech-republics-response-to-the-coronavirus-
pandemic/. 
50 C. Mateus, “Portugal’s Response to the Coronavirus Pandemic” 18 May 2020.  
https://www.cambridge.org/core/blog/2020/04/07/portugals-response-to-the-coronavirus-pandemic/  S. 
Thomas, “Ireland’s Response to the Coronavirus Pandemic”, 15 May 2020. 
https://www.cambridge.org/core/blog/2020/04/06/irelands-response-to-the-coronavirus-pandemic/.  
51 Consolidated Version of the Treaty on European Union – Protocol (No. 26) on Services of General Interest. 
Official Journal 115 , 09/05/2008 P. 0308 – 0308. 
52 T. Prosser, “EU competition law and public services”, Chapter 7 in (eds) E. Mossialos, G. Permanand, R. 
Baeten and T.K. Hervey, Health Systems Governance in Europe: The Role of European Union Law and Policy, 
Cambridge University Press, Cambridge 2010. 
53 C 116 I/7. 8.4.2020. European Commission, Communication from the Commission, Temporary Framework 
for assessing antitrust issues related to business cooperation in response to situations of urgency stemming 
from the current COVID-19 outbreak (2020/C 116 I/02).  European Competition Network (ECN), “Antitrust: 
Joint statement by the European Competition Network (ECN) on application of competition law during the 
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was decided in the context of the temporary framework. However, relaxation, even for an 
extended period, is a different proposition to a longer-term evolution of approach to 
determining an appropriate role for, and applicability of, Union competition law54 as “indirect” 
responses may extend beyond “temporary”, and even take on a more permanent character. 
While recent calls for solidarity55 may find expression in questions of the applicability of Union 
competition law,56 perhaps a more interconnected approach can be seen with exploring the 
SGEI exception. 
IV. CONCLUSION 
Given the political salience, if not legal effect, of Article 168(7) TFEU, it is unsurprising that 
COVID-19 response proposals should be shaped around this, suggesting that Member States 
have a significant role to play in a European Health Union alongside other measures, inter alia, 
based on the public health aspects of Article 168 TFEU. A closer reading of Article 168(7) 
TFEU has highlighted questions of defining “national health policy” relative to Union activities, 
how longer-term continuity of non-COVID-19-related healthcare may offer a different 
perspective on Member State-Union interaction, and how wider Union fiscal policy in 
particular may shape practical consequences for Member State responsibility for their 
healthcare systems, suggesting that differentiated approaches may lead to paradoxes of 




                                                          
Corona crisis”, March 2020. https://ec.europa.eu/competition/ecn/202003_joint-statement_ecn_corona-
crisis.pdf. 
Communication from the Commission, Temporary Framework for State Aid Measures to Support the 
Economy in the current COVID-19 Outbreak. 
https://ec.europa.eu/competition/state_aid/what_is_new/TF_consolidated_version_amended_3_april_8_may_
and_29_june_2020_en.pdf.  
54 Indeed, the question of the future of state aid is considered by Stefan and Biondi in this issue. 
55 De Ruijter and Greer, supra note 7.  
56 In reflection of recent Court of Justice case law, specifically Case C-74/16 Congregación de Escuelas Pías 
Provincia Betania, 27 June 2017, ECLI:EU:C:2017:496, which enabled the development of a “three-prong test” by 
van de Gronden based on solidarity to determine applicability of Union competition law. See J.W. van de 
Gronden, “Services of general interest and the concept of undertaking: does EU competition law apply?” 
(2018)  World Competition 41, 197–224. This test has recently been analysed in the healthcare context for 
the first time – see J.W. van de Gronden and M. Guy, “The role of EU competition law in healthcare and the 
“undertaking” concept”, (2020) Health Economics, Policy and Law, FirstView. 
57 For example, in April 2020, Greece was considered a success story in terms of healthcare, but likely to be 
the worst-hit Member State in terms of the economic downturn of the pandemic. V. Hatzopolous, “Taming 
the COVID-19, not the GDPR: the case of Greece”, https://blogdroiteuropeen.com/2020/07/04/taming-the-
covid-19-not-the-gdpr-the-case-of-greece-by-vassilis-hatzopoulos/  
